Clinical Trials 844 Views Nykode announces positive final results from its Phase 2 trial Malin Otmani April 19, 2023 Nykode Therapeutics has announced results …
Clinical Trials 590 Views Preclinical data validate Evaxion’s AI-based platform Malin Otmani April 19, 2023 Evaxion Biotech has announced preclinical …
Clinical Trials 636 Views Affibody presents long-term results with izokibep Malin Otmani April 19, 2023 Affibody have shared long-term 46-week …
Clinical Trials 1208 Views EXACT Therapeutics presents encouraging data Malin Otmani March 30, 2023 The company has presented data …
Clinical Trials 4891 Views Affibody presents topline 12-week data Malin Otmani March 20, 2023 Affibody has announced that data …
Clinical Trials 5445 Views First patient dosed in Targovax study Malin Otmani March 17, 2023 Targovax has announced that the …
Clinical Trials 5211 Views First patient dosed in BerGenBio Phase 1b/2a trial Malin Otmani March 14, 2023 The company has announced that …
Clinical Trials 5539 Views Calliditas announces positive topline results Malin Otmani March 13, 2023 Calliditas Therapeutics has announced results …
Clinical Trials 6324 Views Ascelia Pharma achieves major milestone Malin Otmani February 27, 2023 The company has announced the …
Clinical Trials 6081 Views Cantargia advances its TRIFOUR trial Malin Otmani February 27, 2023 The company has reported favorable …
Clinical Trials 6434 Views Modus Therapeutics announces positive Phase 1b data Malin Otmani February 22, 2023 Modus Therapeutics has announced positive …
Clinical Trials 6562 Views BerGenBio announces positive Phase 2 data Malin Otmani February 21, 2023 The company has announced topline …
Clinical Trials 2224 Views Half of the patients dosed in Guard Therapeutics’ AKITA study Malin Otmani February 14, 2023 Guard Therapeutics have announced that …
Clinical Trials 4197 Views Heartseed and Novo Nordisk announce first patient dosed in clinical study Malin Otmani February 13, 2023 Heartseed has successfully dosed the …
Clinical Trials 1519 Views Promising preclinical mRNA vaccine data from Evaxion Malin Otmani February 8, 2023 Evaxion Biotech and Pantherna Therapeutics …
Business article 1793 Views Last patient included in AlzeCure’s Phase II trial Malin Otmani February 1, 2023 The last patient has now …